InvestSMART

Acusensus Limited (ASX: ACE) - Announcements

Current share price for ACE : $1.225 0.015 (1.21%)+

ASX company news and announcements for Acusensus Limited (ACE) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Acusensus Limited (ACE) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Acusensus Limited (ACE), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Acusensus Limited (ACE)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$208 Change in substantial holding 13 Dec 2024 5:35PM $1.160 $1.225 risen by 5.60%
$208 Change in substantial holding 13 Dec 2024 5:35PM $1.160 $1.225 risen by 5.60%
$208 Appendix 3Y - Change of Director's Interest Notice 13 Dec 2024 5:18PM $1.160 $1.225 risen by 5.60%
$208 Becoming a substantial holder 12 Dec 2024 5:30PM $1.150 $1.225 risen by 6.52%
$208 Placement Cleansing Notice 12 Dec 2024 8:20AM $1.130 $1.225 risen by 8.41%
$208 Mobile Phone & Seatbelt Contract Expansion in QLD 11 Dec 2024 8:20AM $1.000 $1.225 risen by 22.50%
$208 Application for quotation of securities - ACE 11 Dec 2024 8:20AM $1.000 $1.225 risen by 22.50%
$208 Acusensus Share Purchase Plan opens 9 Dec 2024 8:19AM $1.030 $1.225 risen by 18.93%
$208 Share Purchase Plan Cleansing Notice 9 Dec 2024 8:18AM $1.030 $1.225 risen by 18.93%
$208 Successful completion of Institutional Placement 5 Dec 2024 12:04PM $0.900 $1.225 risen by 36.11%
$208 Proposed issue of securities - ACE 4 Dec 2024 10:15AM $0.900 $1.225 risen by 36.11%
$208 Equity Raising Investor Presentation 4 Dec 2024 9:54AM $0.900 $1.225 risen by 36.11%
$208 Acusensus announces Institutional Placement and SPP 4 Dec 2024 9:53AM $0.900 $1.225 risen by 36.11%
$208 Acusensus successful supplier for NZ mobile speed program 4 Dec 2024 9:37AM $0.900 $1.225 risen by 36.11%
$208 Trading Halt 4 Dec 2024 9:29AM $0.900 $1.225 risen by 36.11%
$208 Application for quotation of securities - ACE 3 Dec 2024 4:39PM $0.900 $1.225 risen by 36.11%
$208 Appendix 3Y - Change of Director's Interest Notice 22 Nov 2024 4:45PM $0.940 $1.225 risen by 30.32%
$208 Notification regarding unquoted securities - ACE 22 Nov 2024 4:30PM $0.940 $1.225 risen by 30.32%
$208 Results of 2024 Annual General Meeting 21 Nov 2024 3:49PM $0.930 $1.225 risen by 31.72%
$208 2024 AGM Presentation including trading update 21 Nov 2024 8:25AM $0.895 $1.225 risen by 36.87%
$208 2024 AGM Addresses of the Chair and the Managing Director 21 Nov 2024 8:24AM $0.895 $1.225 risen by 36.87%
$208 Acusensus signs introductory road worker safety contract 20 Nov 2024 8:19AM $0.875 $1.225 risen by 40%
$208 Q1 FY25 Quarterly Activities Report and Appendix 4C 22 Oct 2024 8:16AM $0.900 $1.225 risen by 36.11%
$208 Acusensus wins tender for WA multi-function contract 21 Oct 2024 8:20AM $0.820 $1.225 risen by 49.39%
$208 2024 Notice of Annual General Meeting 17 Oct 2024 9:25AM $0.840 $1.225 risen by 45.83%

101 - 125 of 349 results

Page 5 of 14

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.